115 related articles for article (PubMed ID: 11527060)
1. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study.
Maillefert JF; Aho LS; El Maghraoui A; Dougados M; Roux C
Osteoporos Int; 2001; 12(7):605-9. PubMed ID: 11527060
[TBL] [Abstract][Full Text] [Related]
2. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes?
Kaya A; Ozgocmen S; Kamanli A; Ardicoglu O
Med Princ Pract; 2009; 18(6):470-6. PubMed ID: 19797924
[TBL] [Abstract][Full Text] [Related]
3. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.
Kang KY; Lee KY; Kwok SK; Ju JH; Park KS; Hong YS; Kim HY; Park SH
Joint Bone Spine; 2011 Mar; 78(2):188-93. PubMed ID: 20621536
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases.
Wang DM; Zeng QY; Chen SB; Gong Y; Hou ZD; Xiao ZY
Clin Exp Rheumatol; 2015; 33(4):465-70. PubMed ID: 25962324
[TBL] [Abstract][Full Text] [Related]
5. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.
Uaratanawong S; Deesomchok U; Hiransuttikul N; Uaratanawong S
J Med Assoc Thai; 2004 Nov; 87(11):1374-9. PubMed ID: 15825716
[TBL] [Abstract][Full Text] [Related]
6. Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study.
van der Weijden MA; van Denderen JC; Lems WF; Nurmohamed MT; Dijkmans BA; van der Horst-Bruinsma IE
J Rheumatol; 2016 Apr; 43(4):758-64. PubMed ID: 26879348
[TBL] [Abstract][Full Text] [Related]
7. Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.
Deminger A; Klingberg E; Lorentzon M; Geijer M; Göthlin J; Hedberg M; Rehnberg E; Carlsten H; Jacobsson LT; Forsblad-d'Elia H
Arthritis Res Ther; 2017 Dec; 19(1):273. PubMed ID: 29216909
[TBL] [Abstract][Full Text] [Related]
8. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
[TBL] [Abstract][Full Text] [Related]
9. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment.
Briot K; Gossec L; Kolta S; Dougados M; Roux C
J Rheumatol; 2008 May; 35(5):855-61. PubMed ID: 18381782
[TBL] [Abstract][Full Text] [Related]
10. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.
Grazio S; Kusić Z; Cvijetić S; Grubišić F; Balenović A; Nemčić T; Matijević-Mikelić V; Punda M; Sieper J
Rheumatol Int; 2012 Sep; 32(9):2801-8. PubMed ID: 21858541
[TBL] [Abstract][Full Text] [Related]
11. Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort.
Briot K; Durnez A; Paternotte S; Miceli-Richard C; Dougados M; Roux C
Ann Rheum Dis; 2013 Dec; 72(12):1914-9. PubMed ID: 23161904
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement.
Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL
Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases.
Mullaji AB; Upadhyay SS; Ho EK
J Bone Joint Surg Br; 1994 Jul; 76(4):660-5. PubMed ID: 8027159
[TBL] [Abstract][Full Text] [Related]
16. Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis.
Haroon NN; Sriganthan J; Al Ghanim N; Inman RD; Cheung AM
Semin Arthritis Rheum; 2014 Oct; 44(2):155-61. PubMed ID: 24909809
[TBL] [Abstract][Full Text] [Related]
17. Low levels of serum uric Acid increase the risk of low bone mineral density in young male patients with ankylosing spondylitis.
Kang KY; Hong YS; Park SH; Ju JH
J Rheumatol; 2015 Jun; 42(6):968-74. PubMed ID: 25834199
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density changes in women with systemic lupus erythematosus.
Boyanov M; Robeva R; Popivanov P
Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
[TBL] [Abstract][Full Text] [Related]
19. Serum Uric Acid Shows Inverted "U" Type Correlation with Osteoporosis in Chinese Ankylosing Spondylitis Patients: A Retrospective Study.
Chen Z; Yang P; Wu Y; Liu X; Yang Y; Song P; Chen YT; Lin C; Xu Q
Med Sci Monit; 2019 Dec; 25():9702-9711. PubMed ID: 31851643
[TBL] [Abstract][Full Text] [Related]
20. Bone edema on magnetic resonance imaging is highly associated with low bone mineral density in patients with ankylosing spondylitis.
Wang D; Hou Z; Gong Y; Chen S; Lin L; Xiao Z
PLoS One; 2017; 12(12):e0189569. PubMed ID: 29240803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
